LEGIONELLA PNEUMOPHILA IGG/IGM— 510(k) K033051

Name: FDA 510(k) clearance K033051
Creator: U.S. Food and Drug Administration
Published: 2003-11-26

Substantially Equivalent

Trinity Biotech USA

FDA 510(k) clearance K033051 for LEGIONELLA PNEUMOPHILA IGG/IGM, Substantially Equivalent on 2003-11-26. Applicant: Trinity Biotech USA. Device class: 2.

Clearance details

Applicant: Trinity Biotech USA
Product code: Code MJH
Device class: Class 2
Regulation: 21 CFR 866.3300
Advisory panel: Microbiology
Date received: 2003-09-29
Decision date: 2003-11-26
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Jamestown, NY, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code MJH

view all

K191184 — ImmuView S pneumoniae and L pneumophila Urinary Antigen Test2020-03-05
K163273 — TRU Legionella2017-02-21
K113190 — TRU LEGIONELLA2012-02-24
K061496 — SAS LEGIONELLA TEST, SAS LEGIONELLA DIPSTICK TEST2007-06-28
K070522 — MODIFICATION TO: BINAX NOW LEGIONELLA URINARY ANTIGEN TEST, #852-000,852-0122007-03-15

More clearances from Trinity Biotech USA

view all

K140455 — CAPTIA MEASLES IGM2014-05-22
K033105 — CAPTIA HSV 1 IGG TYPE SPECIFIC ELISA KIT2004-07-13
K033106 — CAPTIA HSV 2 IGG TYPE SPECIFIC ELISA KIT2004-07-13
K033064 — MYCOPLASMA IGG2003-11-26
K033067 — PYLORI IGG2003-11-26

Data sourced from openFDA. This site is unofficial and independent of the FDA.